San Diego – October 19, 2026 -- The U.S. Food and Drug Administration has pushed the decision date for Capricor Therapeutics' Deramiocel Biologics License Application by three months, from August 22, 2026 to November 22, 2026, after classifying the company's latest data submission as a major amendment.

Deramiocel is an investigational cell therapy for Duchenne muscular dystrophy (DMD). Capricor (NASDAQ: CAPR) disclosed the extension of the Prescription Drug User Fee Act (PDUFA) target action date on the day of release.

Farnborough – October 18, 2026 -- De Havilland Aircraft of Canada has received European Union Aviation Safety Agency (EASA) certification for the Twin Otter Classic 300-G, clearing deliveries to operators across Europe and other regions that recognize EASA approval.

Zimex Aviation flies first EASA-certified Classic 300-G in commercial service

The first EASA-certified aircraft has already been delivered to Switzerland-based Zimex Aviation, which is the launch customer and first operator. The aircraft is in commercial operation.

United States – October 17, 2026 -- AdvaMed has told the U.S. Copyright Office that software built to diagnose, configure and service a medical device is a distinct product and should not be treated like the software that operates the device.

Selangor -- Founder Group Limited (Nasdaq: FGL) has until November 2, 2026, to submit a plan to Nasdaq's staff for regaining compliance after the exchange found the company no longer meets the minimum of 500,000 publicly held shares required for continued listing.

Irvine – October 17, 2026 -- Masimo, a Danaher company, has received FDA 510(k) clearance for atrial fibrillation (AFib) detection on its Radius VSM monitor. The feature showed 97% sensitivity and 100% specificity in clinical validation testing, according to the company.

Shanghai – October 17, 2026 -- The U.S. Food and Drug Administration has granted Orphan Drug Designation to GT801, the lead in vivo CAR-T candidate of Vivacta Biotechnology (Shanghai) Co., Ltd., for autoimmune hemolytic anemia (AIHA). Vivacta Bio was spun out of Beijing Grit Biotherapeutics' in vivo CAR-T platform on June 25, 2025.

Pittsburgh – October 16, 2026 -- The U.S. Food and Drug Administration (FDA) has approved Viatris Inc.'s RYZUMVI (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults, adding a second indication to a product already on the U.S. market.

RYZUMVI is currently approved in the United States for pharmacologically-induced mydriasis and is the only commercially available FDA-approved product for that use. The presbyopia approval expands its label beyond that use.

Los Angeles – October 16, 2026 -- California approved 433 oil well drilling permits in the first nine months of 2026, a 277% jump over the 115 approved across all of 2023 through 2025, according to analysis by Consumer Watchdog and FracTracker Alliance of state data.

Approvals rose another 22.7% between the first half of the year and the first nine months. The figures come from the California Department of Geological Energy Management (CalGEM).

Pleasanton – October 16, 2026 -- n6 Tec, Inc. has received ISO 13485:2016 certification from Intertek for its quality management system, covering the manufacture and service of genetic research instrumentation at its Pleasanton, California headquarters.

Certificate 0259003 runs through October 2029

Intertek issued the initial certificate on October 12, 2026. It is valid through October 11, 2029, subject to ongoing surveillance by the certification body.

Little Ferry, N.J. – October 16, 2026 -- Eventide Communications has completed an independent SOC 2 Type 1 examination covering the security and availability of its cloud-based mission-critical recording and analytics solutions, giving public safety buyers third-party evidence of its controls.